ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1420	National Cancer Institute	Html	en	Prostate Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.	hereditary prostate cancer 0.542395 prostate biopsy 0.533126 dutasteride group vs 0.459041 skin cancer 0.446356 prostate cancer period 0.528407 cancer mortality rates 0.459369 prostate volume subgroups 0.508967 Prostate Cancer Events 0.558338 finasteride group versus 0.448086 rat ventral prostate 0.516053 high-grade tumors 0.479135 high-grade cancer 0.454168 prostate cancer-specific mortality 0.525559 occult prostate cancer 0.561891 high-grade prostate cancer 0.548137 prostate preventive effects 0.507979 relative risk reduction 0.446967 radical prostatectomy 0.460894 prostate cancer mortality 0.534065 prostate cancer chemoprevention 0.531007 dietary fat 0.445789 men 0.4492 Cancer Events trial 0.451937 negative prostate biopsy 0.515564	digital rectal examination 0.454846 dutasteride group 0.460003 fat intake 0.450377 Cancer Prevention Trial 0.500983 prostate digital 0.500034 prostate cancer risk 0.564597 placebo group 0.469544 incident prostate cancer 0.532469 Cancer Events study 0.447937 prostate volume 0.517049 absolute risk reduction 0.495169 low biologic risk 0.447169 finasteride group 0.448145 prostate cancer 0.910772 Gleason 0.458954 clinical prostate cancer 0.556069 pancake-appearing prostate 0.508749 Prostate Cancer Prevention 0.595277 prostate cancer. 0.505972 prostate cancer death. 0.562581 statistically significant difference 0.470146 prostate cancers 0.559985 human prostate cancer 0.538634	CLICK HERE
1618	National Cancer Institute	Html	en	Late Effects of Treatment for Childhood Cancer (PDQ®)–Patient Version	The treatment of cancer may cause health problems (late effects) for childhood cancer survivors months or years after successful treatment has ended. Get information about the long-term physical, psychological and social effects of treatment for childhood cancer in this expert-reviewed summary.	childhood cancers 0.431043 cancer treatment 0.371211 body 0.373967 childhood cancer survivors 0.770496 chemotherapy 0.372336 PDQ cancer information 0.35879 total-body irradiation 0.354372 ovarian late effects 0.364333 bile duct 0.348106 talk 0.386582 chest radiation treatment 0.353115 kidney late effects 0.373747 joint late effects 0.365129 cancer information summary 0.349224 stem cell transplant 0.480939 pancreatic late effects 0.367016 heart 0.364096 symptoms 0.373794 health problems 0.529948 tests 0.430651 primary cancer diagnosis 0.352818 radiation therapy 0.438948 following 0.347799 hormone replacement therapy 0.348511	late effects 0.94258 treatment 0.571093 blood vessel 0.385075 primary cancer 0.359907 signs 0.42599 related health problems 0.511763 procedures 0.374731 National Cancer Institute 0.350345 spinal cord 0.453656 disease 0.351393 breast cancer risk 0.350432 breast cancer 0.372761 brain tumor 0.349819 thyroid late effects 0.395111 brain 0.380353 doctor 0.354325 radiation treatment 0.379126 radiation 0.476283 acute lymphoblastic leukemia 0.349699 health habits 0.363956 neuroendocrine late effects 0.359016 high blood pressure 0.347712 nonmelanoma skin cancer 0.356812 lung late effects 0.390136	CLICK HERE
1649	National Cancer Institute	Html	en	Aromatherapy and Essential Oils (PDQ®)–Patient Version	Expert-reviewed information summary about the use of aromatherapy and essential oils to improve the quality of life of cancer patients.	PDQ Aromatherapy 0.51751 cancer treatment 0.518478 modern aromatherapy 0.502296 certain essential oils 0.545828 aromatherapy training 0.496531 PDQ cancer information 0.582174 Cancer Complementary 0.49782 hormone -like effects 0.496783 clinical trials 0.646919 cancer information summary 0.54045 aromatherapy massage 0.496545 alternative cancer therapies 0.488792 clinical trial 0.515897 CAM cancer research 0.479249 patients 0.520207 cancer patients 0.499565 Aromatherapy products 0.529674 bergamot essential oil 0.494855 literature discuss aromatherapy 0.518185 NCI PDQ cancer 0.50787 cancer information database 0.486869 aromatherapy 0.710126 international aromatherapy programs 0.515466 Therapies Editorial Board 0.490712	essential oils 0.964677 cancer information 0.591001 treatment 0.540034 Complementary Therapies Editorial 0.514222 Drug Administration 0.547203 Cancer Information Specialist 0.481775 Aromatherapy research 0.515581 tree essential oils 0.64448 Cancer Information Service 0.537651 tree essential oil 0.496279 Antibacterial essential oils 0.531896 National Cancer Institute 0.639762 alternative medicine 0.561892 standard aromatherapy certification 0.518782 term aromatherapy 0.502247 orange essential oil 0.494346 aromatherapy courses 0.496618 tea tree 0.549957 cancer clinical trials 0.48888 alternative therapies 0.505894 ginger essential oil 0.493305 cancer information summaries 0.487611 cancer 0.667969 Holistic Aromatherapy 0.506338	CLICK HERE
1661	National Cancer Institute	Html	en	Antineoplastons (PDQ®)–Health Professional Version	Expert-reviewed information summary about antineoplastons as a treatment for people with cancer.	various tumor suppressor 0.673325 high-risk pediatric patients 0.613742 cell lines 0.732784 antineoplaston A10. 0.614589 steady state concentration 0.632482 mean steady state 0.62987 stable disease 0.629423 tumor suppressor genes 0.670419 antineoplaston a10 0.785651 multiple brain metastases 0.666381 clinical trials 0.642258 cancer cell line 0.621623 cancer information summary 0.628466 highest tumor response 0.628298 patients 0.960903 cancer patients 0.782838 average dose 0.662612 human colon cancer 0.66679 tumor progression 0.629611 colon cancer cells 0.664834 antineoplaston treatment 0.679278 complete tumor response 0.726436 metastatic brain tumor 0.711993 study 0.663173 neutrophil apoptosis 0.623745	Human/Clinical Studies section 0.637915 neoplastic cell lines 0.689948 human blood 0.654645 cancer cells 0.75191 animal tumor systems 0.612469 National Cancer Institute 0.656232 tumor growth 0.643714 breast cancer patients 0.772855 partial tumor response 0.663127 AS2-1 0.676129 antineoplaston therapy 0.747438 white blood cell 0.631532 antineoplaston A. 0.675544 abnormal cells 0.630356 human tumor tissue. 0.623365 human urine 0.617971 antineoplastons 0.86378 experimental cancer therapy 0.633011 chronic lymphocytic leukemia 0.610232 tumor response 0.767878 objective tumor response 0.612044 naturally occurring biochemical 0.637098 antineoplastons A10 0.665762 cancer 0.805413	CLICK HERE
1890	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama).	estadio lllC 0.524041 siguientes procedimientos 0.510716 siguientes aspectos 0.534365 causa efectos 0.516747 estadio lllB 0.524512 estadio lllA 0.524967 rayos x 0.508877 causó hinchazón 0.508591 cuáles lesiones 0.508991 Breast Cancer Risk 0.519727 epidérmico humano tipo 0.51911 carcinoma lobulillar 0.618686 crecimiento llamada her2 0.513006 cuerpo llamada ecograma 0.530459 pared torácica.ampliar mastectomía 0.517551 siguientes estadios 0.514163 proteína tipo factor 0.510936 células madre 0.671831 estadio iv 0.594708 ganglio linfático centinela 0.990128 Oncotype DX 0.510563 estadio ib 0.547143 prueba ayuda 0.524997 enlace drugs approved 0.56421 estadio ia 0.546556	mama.ampliar cirugía 0.509968 CLIS.Ampliar Carcinoma lobulillar 0.520349 efectos tardíos 0.515275 proteína her2 0.510017 Características genéticas 0.510197 bulbos minúsculos 0.511767 Breast Cancer Treatment 0.519669 cuántos genes 0.511329 incisión separada.ampliar mastectomía 0.517497 estadio iiia 0.543785 antecedentes familiares 0.532316 cabo pruebas 0.51404 estadio iiic 0.596075 estadio llB 0.525023 estadio llA 0.525437 Gynecologic Cancers 0.511174 mama.ampliar mamografía 0.511179 proteína llamada mTOR 0.510238 Breast Cancer 0.623769 sección cáncer 0.744984 pequeñas llamadas lobulillos 0.518854 genes brca1 0.512161 siguientes pruebas 0.535819 siguientes sumarios 0.517679	CLICK HERE
2015	National Cancer Institute	Html	es	Prevención del cáncer de pulmón (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que influirían en el riesgo de presentar cáncer de pulmón y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	cigarrillo encendido 0.533546 voluntarios sanos 0.521783 secciones llamadas lóbulos 0.564444 factor protector 0.54356 rayos x 0.525531 rayos gamma 0.526755 altas cantidades 0.523911 vías respiratorias 0.534485 suplementos vitamina 0.527073 membrana delgada llamada 0.563077 National Cancer Institute 0.526876 Más personas 0.538369 Instituto Nacional 0.548081	antecedentes familiares 0.770813 siguientes factores 0.598507 Physician Data Query 0.601335 gas radón 0.544843 prevención revisa 0.523285 PDQ Prevención 0.542908 siguientes sustancias 0.533013 Menor exposición 0.544963 órganos respiratorios 0.535883 principal causa 0.53309 factores protectores 0.947087 siguientes sumarios 0.567797 suplementos alimenticios 0.525893	CLICK HERE
2037	National Cancer Institute	Html	es	Prevención del cáncer de piel (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.	skin cancer 0.991265 cutaneous melanoma 0.469757 Lippincott Williams 0.41932 skin cancer prevention 0.612003 prevent skin 0.440602 protectores solares 0.469609 Williams GM 0.418343 queratosis solares 0.585992 Sin embargo 0.685934 protector solar 0.843096 American Cancer Society 0.553421 Prev Med 0.458565 cancer prevention study 0.448174 case-control study 0.424296 Study Group 0.427125 DeVita VT Jr 0.43478 risk factors 0.435855 with nonmelanoma skin 0.42056 isotretinoin-basal cell carcinomas 0.418488 randomized trial 0.462527 exposición solar 0.710997 Natl Cancer Inst 0.487884 8th ed 0.41947 protección solar 0.624745 melanoma risk factors 0.418328	pruebas insuficientes 0.419855 Nambour Skin Cancer 0.466485 cell carcinomas 0.512878 Halliday GM 0.422507 Arch Dermatol 0.425176 Wilson LD 0.417928 Cancer Facts 0.43005 Aasi SZ 0.421096 nevos melanocíticos benignos 0.418665 protector solar ayuda 0.422241 controlled trial 0.45893 protector solar versus 0.425736 Epidemiol Biomarkers Prev 0.463973 exposición solar aguda 0.467654 Cancer Prevention Trial 0.454925 Thomas VD 0.418204 Reduce Actinic Cancer 0.419285 radiación uv 0.425436 randomized controlled trial 0.440826 radiación solar 0.432514 crema base 0.420169 nonmelanoma skin cancer 0.715174 radiación ultravioleta 0.572893 Cancer Study Group 0.420229	CLICK HERE
3653	National Cancer Institute	Html	es	Cannabis y canabinoides (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del Cannabis y canabinoides para el tratamiento de los efectos secundarios relacionados con el tratamiento del cáncer como la náusea y el vómito.	suficiente información 0.303746 American Academy 0.304933 salud masculina 0.30438 Controlled Substances Act 0.309374 estado.ampliar mapa 0.305022 NCI Best Case 0.309795 Ley Boggs 0.304951 ratones modelo 0.329727 Asia central 0.304897 datos bibliográficos pubmed 0.306457 principal canabinoide 0.317402 continuas preocupaciones 0.305444 Instituto Nacional 0.356831 distintos métodos 0.304585 Salud Complementaria 0.311676 Asociación Médica Americana 0.308343 complementarias revisa 0.305401 huésped aguda 0.30517 posibles efectos 0.307656 siglo xix 0.305316 Estados Unidos 0.923075 Investigational New Drug 0.308776 ¿Los beneficios 0.303644 Centro Nacional 0.308445 células madre 0.307765	New Hampshire Avenue 0.305866 creciente interés 0.305364 Drug Administration 0.303686 vía oral 0.438627 medicamentos canabinoides 0.315665 lista i 0.304143 Marijuana Tax Act 0.30965 Men's Health Study 0.308077 siguientes riesgos 0.303989 suficientes pruebas 0.305693 Visuals Online 0.304212 sistema nervioso central 0.330645 Physician Data Query 0.323581 libre uso 0.304331 principal ingrediente 0.304814 receptores canabinoides 0.313898 posibles beneficios 0.304408 página manejo 0.303972 ¿El tratamiento 0.309063 planta cannabis 0.341326 potencial alto 0.304956 medicina complementaria 0.465284 largo tiempo 0.303689 ¿el cannabis 0.355862	CLICK HERE
16684	National Cancer Institute	Html	en	Immunotherapy	Immunotherapy is treatment that helps your immune system fight cancer. Get information about the different types of immunotherapy and what you can expect during treatment.	different ways 0.281527 fatal allergic reactions 0.264895 Certain immunotherapies 0.259316 treatment vaccines 0.275288 cancer cells 0.951751 new healthy cells 0.412417 type 0.312586 adult cancer treatment 0.355067 immune system fight 0.336993 cancer treatment summaries 0.489214 body’s cells 0.328519 white blood cells 0.50706 immune response 0.442108	bladder cancer 0.215882 immunotherapy 0.916869 car t-cell therapy 0.510597 white blood cell 0.291068 biological therapy 0.305661 immune cells 0.541167 normal immune responses 0.430369 immunotherapies 0.36897 different types 0.290719 early skin cancer 0.309312 body fight infections 0.317237 childhood cancer treatment 0.34975 adoptive cell transfer 0.589329	CLICK HERE
16858	National Cancer Institute	Html	en	Monitoring Research Grant Awards	NCI grants management staff regularly monitor individual grants within each budget period and within the overall project period.	program director 0.901745 overall project period 0.737705 Comptroller General 0.577687 documents 0.447442 Grants management officer 0.721935 grants management specialist 0.810551 federal regulation 0.560169 HHS awarding agency 0.720873 NCI staff work 0.714177 assessment 0.459846 progress reports 0.591992 budget period 0.591377 review 0.454674 weaknesses 0.464168 grants management 0.917818 telephone numbers 0.566417 financial reports 0.599567 required retention period 0.705874 reasonable access 0.563534 grant awards 0.568767 responsible GMS 0.614785 award process 0.554431 approved project 0.590335 recipients 0.469243 recipient cash expenditure 0.886855	NCI grants management 0.812999 problems 0.44631 recipient institution 0.874163 United States 0.564008 records 0.447146 audit reports 0.592365 site visits 0.586368 scientific progress 0.547344 Inspector General 0.563508 mutually agreeable course 0.708418 recipient’s inability 0.723309 internal controls 0.570063 Expenditure patterns 0.599349 financial systems 0.589323 pass-through entity 0.56408 monitors individual grants 0.762977 applicant organization 0.594032 unrestricted access 0.5713 principal investigator 0.553317 financial management 0.584417 specific guidelines 0.567884 management systems 0.560429 economic policy 0.555241 grant expenditures 0.689873	CLICK HERE